Secure Access for Pharma & Life Sciences

This white paper explains how Safous Privileged Remote Access protects research and manufacturing environments in pharmaceuticals and life sciences. It is for IT, OT and compliance teams that must secure intellectual property and production systems while giving researchers, technicians and vendors remote access. It covers sector risks, a global pharma manufacturing scenario and how Safous helps.

Download the PDF

Key Challenges in Pharma and Life Sciences

• Connected devices, cloud platforms, AI research tools and collaboration networks add points attackers can target.
• Intellectual property such as drug formulations, trial designs and manufacturing processes is a prime target.
• Attacks on IT and OT systems can halt production, delay approvals and affect patient safety.
• Regulations increasingly require central control of remote, privileged and third-party access with auditable session logs.
• Many organizations lack central oversight of who accessed sensitive IP and trial data, and run multiple tools that create compliance gaps.

How Safous Helps

• Session oversight: real-time alerts, supervised access and time-bound permissions limit misuse of privileged accounts.
• IP protection: identity-based, least-privilege controls restrict access to formulations, trial designs and manufacturing processes.
• Compliance-ready logging: privileged session capture supports controls aligned with HIPAA, 21 CFR Part 11, GDPR, ISO 27001 and ASEAN PDPA frameworks.
• Research collaboration: researchers at multiple sites reach platforms, databases and analytical tools without exposing sensitive data.
• Vendor access: technicians and vendors maintain legacy manufacturing and OT systems without agents, network changes or VPNs.
• Simple deployment: one subscription and one outbound Safous AppGateway.

Frequently Asked Questions

Which regulations does Safous logging help with in life sciences?

The white paper lists HIPAA, 21 CFR Part 11, GDPR, ISO 27001, ASEAN PDPA frameworks and national cybersecurity laws.

How does Safous protect research IP?

It applies identity-based, least-privilege controls so users reach only the formulations, trial designs and processes they are authorized for, and records access.

Can vendors maintain legacy manufacturing systems without a VPN?

Yes. Vendors and technicians get access without agents, network changes or VPNs.

Learn more: regulatory compliance and third-party access.